Related scientific articles (all)

Long term follow up of the EORTC 18952 trial of adjuvant therapy in resected stage IIB-III cutaneous melanoma patients comparing intermediate doses of interferon-alpha-2b (IFN) with observation: Ulceration of primary is key determinant for IFN-sensit

Authors : Eggermont AM, Suciu S, Rutkowski P, Kruit WH, Punt CJ, Dummer R, Sales F, Keilholz U, de Schaetzen G, Testori A
Year : 2016
Journal : Eur J Cancer
Volume : 55
Pages : 111-121

Cancer des non fumeurs

Authors : Berghmans T
Year : 2016
Journal : Rev Med Brux
Volume : 8
Pages : 411-16

A 38 years old female with inflammatory myofibroblastic tumor and lactic acidosis.

Authors : Gorham J, Liberale G, Haydar HN, de Saint-Aubain de Somerhausen N, Meert AP
Year : 2016
Journal : Rev Med Brux
Volume : 37
Pages : 104-7

Phase I Study of the Prolactin Receptor Antagonist LFA102 in Metastatic Breast and Castration-Resistant Prostate Cancer.

Authors : Agarwal N, Machiels JP, Suárez C, Lewis N, Higgins M, Wisinski K, Awada A, Maur M, Stein M, Hwang A, Mosher R, Wasserman E, Wu G, Zhang H, Zieba R, Elmeliegy M
Year : 2016
Journal : Oncologist
Volume : 21(5)
Pages : 535-6

The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer Recurrence.

Authors : Ignatiadis M, Azim HA Jr, Desmedt C, Veys I, Larsimont D, Salgado R, Lyng MB, Viale G, Leyland-Jones B, Giobbie-Hurder A, Kammler R, Dell orto P, Rothé F, Laïos I, Ditzel HJ, Regan MM, Piccart-Gebhart M, Michiels S, Sotiriou C
Year : 2016
Journal : JAMA Oncol
Volume : 2(2)
Pages : 217-24

Adjuvant chemotherapy in elderly patients with breast cancer: key challenges.

Authors : Pondé N, Dal Lago L, Azim HA Jr
Year : 2016
Journal : Expert Rev Anticancer Ther
Volume : 16(6)
Pages : 661-71

Improved Treatment of Breast Cancer with Anti-HER2 Therapy Requires Interleukin-21 Signaling in CD8+ T Cells.

Authors : Mittal D, Caramia F, Michiels S, Joensuu H, Kellokumpu-Lehtinen PL, Sotiriou C, Loi S, Smyth MJ
Year : 2016
Journal : Cancer Res
Volume : 76
Pages : 264-74

Comparing conventional laparoscopic to robotic-assisted extended pelvic lymph node dissection in men with intermediate and high-risk prostate cancer: a matched-pair analysis.

Authors : Albisinni S, Aoun F, Le Dinh D, Zanaty M, Hawaux E, Peltier A, Van Velthoven R
Year : 2016
Journal : Minerva Urol Nefrol
Volume : 28(25)
Pages : 2941-48

News on the medical treatment of young women with early-stage HER2-negative breast cancer.

Authors : Lambertini M, Poggio F, Vaglica M, Blondeaux E, Del Mastro L
Year : 2016
Journal : Expert Opin Pharmacother
Volume : 17
Pages : 1643-1655

L'euthanasie et la gestion de fin de vie: un débat éthique permanent.

Authors : Berghmans T
Year : 2016
Journal : Rev Med Brux
Volume : 37(2)
Pages : 69

Opioid-free anesthesia: what about patient comfort? A prospective,randomized, controlled trial

Authors : Hontoir S, Saxena S, Gatto P, Khalife M, Ben Aziz M, Paesmans M, Sosnowski M
Year : 2016
Journal : Acta Anaesthesiol Belg
Volume : 67
Pages : 183-190

Feasibility Study of EndoTAG-1, a Tumor Endothelial Targeting Agent, in Combination with Paclitaxel followed by FEC as Induction Therapy in HER2-Negative Breast Cancer.

Authors : Ignatiadis M, Zardavas D, Lemort M, Wilke C, Vanderbeeken MC, Dhondt V, de Azambuja E, Gombos A, Lebrun F, Dal Lago L, Bustin F, Maetens M, Ameye L, Veys I, Michiels S, Paesmans M, Larsimont D, Sotiriou C, Nogaret JM, Piccart-Gebhart M, Awada A
Year : 2016
Journal : PLoS One
Volume : 11(7)
Pages : e0154009

Missing metastases as a model to challenge current therapeutic algorithms in colorectal liver metastases.

Authors : Lucidi V, Hendlisz A, Van Laethem JL, Donckier V
Year : 2016
Journal : World J Gastroenterol
Volume : 22
Pages : 3937-44

Are Intensive Cares Worthwhile for Breast Cancer Patients: The Experience of an Oncological ICU.

Authors : Destrebecq V, Ameye L, Berghmans T, Paesmans M, Sculier JP, Meert AP
Year : 2016
Journal : Front Med (Lausanne)
Volume : 3
Pages : 50

Low-level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 2: proposed applications and treatment protocols.

Authors : Zecha JA, Raber-Durlacher JE, Nair RG, Epstein JB, Elad S, Hamblin MR, Barasch A, Migliorati CA, Milstein DM, Genot-Klastersky MT, Lansaat L, van der Brink R, Arnabat-Dominguez J, van der Molen L, Jacobi I, van Diessen J, de Lange J, Smeele LE, Schubert MM, Bensadoun RJ
Year : 2016
Journal : Support Care Cancer
Volume : 24(6)
Pages : 2793-805

Phase II study of necitumumab plus modified FOLFOX6 as first-line treatment in patients with locally advanced or metastatic colorectal cancer.

Authors : Elez E, Hendlisz A, Delaunoit T, Sastre J, Cervantes A, Varea R, Chao G, Wallin J, Tabernero J
Year : 2016
Journal : Br J Cancer
Volume : 114(4)
Pages : 372-80

Fluorescence Imaging After Indocyanine Green Injection for Detection of Peritoneal Metastases in Patients Undergoing Cytoreductive Surgery for Peritoneal Carcinomatosis From Colorectal Cancer: A Pilot Study.

Authors : Liberale G, Vankerckhove S, Caldon MG, Ahmed B, Moreau M, Nakadi IE, Larsimont D, Donckier V, Bourgeois P
Year : 2016
Journal : Ann Surg
Volume : 264
Pages : 1110-1115

Epstein-Barr Virus Infection of Mammary Epithelial Cells Promotes Malignant Transformation.

Authors : Hu H, Luo ML, Desmedt C, Nabavi S, Yadegarynia S, Hong A, Konstantinopoulos PA, Gabrielson E, Hines-Boykin R, Pihan G, Yuan X, Sotiriou C, Dittmer DP, Fingeroth JD, Wulf GM
Year : 2016
Journal : EBioMedicine
Volume : 9
Pages : 148-60

Dispositifs intra-utérins au lévonorgestrel et risque de cancer du sein ?

Authors : Sculier JP
Year : 2016
Journal : Minerva.ebm
Volume : -
Pages : -

A prospective clinical trial of HIFU hemiablation for clinically localized prostate cancer.

Authors : Van Velthoven R, Aoun F, Marcelis Q, Albisinni S, Zanaty M, Lemort M, Peltier A, Limani K
Year : 2016
Journal : Prostate Cancer Prostatic Dis
Volume : 19(1)
Pages : 79-83